Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Craniofac Surg ; 26(7): e603-5, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26468837

ABSTRACT

The blowout fractures may be classified as pure or impure depending on the associated structures. There are 2 main theories attempting to describe the mechanism of injury, the hydraulic, and blocking mechanism. The complications of this type of fracture may involve diplopia, enophthalmos, and ocular movement restriction. Several materials are available for the reconstruction of orbital floor, including the titanium mesh, which present great properties, such as easy modeling and stabilization, small thickness, and shape maintenance. There, however, are disadvantages such as the possibility of adherence formation. The aim of this report is to describe the case of a patient with an 8-month blowout fracture sequel, presenting extensive enophthalmos and treated by affixing a titanium mesh associated with bovine pericardium membrane in the orbital floor. Therefore, based on a 2-year follow-up, it was possible to observe how effective the association between these 2 materials in solving the case was.


Subject(s)
Biocompatible Materials/chemistry , Enophthalmos/surgery , Membranes, Artificial , Pericardium , Plastic Surgery Procedures/methods , Surgical Mesh , Titanium/chemistry , Animals , Cattle , Diplopia/etiology , Enophthalmos/etiology , Female , Follow-Up Studies , Humans , Middle Aged , Ocular Motility Disorders/etiology , Orbit/surgery , Orbital Fractures/complications , Orbital Fractures/surgery , Plastic Surgery Procedures/instrumentation
3.
J Craniofac Surg ; 26(7): e606-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26468839

ABSTRACT

Bisphosphonates are widely used for treatment or prevention of bone diseases characterized by high osteoclastic activity. Among the oral medicines used to treat osteoporosis, alendronate has been often used. Despite of the low rate of complications on its use, cases of osteonecrosis of the jaw have been reported on literature after tooth extractions. The main symptoms include pain, tooth mobility, swelling, erythema, and ulceration. The risk factors related to osteonecrosis of the jaw associated with bisphosphonate are exposition time to the medicine, routes of administration, and oral surgical procedures performed. The aim of this work is to report a case of a patient showing osteonecrosis of the jaw associated with the use of oral bisphosphonates after tooth extractions. The patient was treated through the suspension of the alendronate with the removal of the necrotic tissue and the foci of infection. After a year's follow-up, the patient showed no recurrence signs. From the foregoing, the interruption of the alendronate use and the surgical treatment associated to antibiotic therapy showed effective on the patient's treatment.


Subject(s)
Alendronate/adverse effects , Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology , Bone Density Conservation Agents/adverse effects , Mandibular Diseases/chemically induced , Tooth Extraction/adverse effects , Administration, Oral , Aged , Alendronate/administration & dosage , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local/therapeutic use , Bone Density Conservation Agents/administration & dosage , Chlorhexidine/therapeutic use , Clindamycin/therapeutic use , Debridement/methods , Female , Follow-Up Studies , Humans , Mouthwashes/therapeutic use , Osteoporosis, Postmenopausal/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...